Evidence map›Paper›PMID 34449079›Full record

ArticlePhotochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology2021

A cross-sectional questionnaire study in a phototherapy unit during COVID-19.

Francine Batista Costa, Patrícia Lima Baptista, Rodrigo Pereira Duquia

Abstract read
In one paragraph

Article in Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Francine Batista CostaDepartment of Dermatology, Santa Casa de Misericórdia de Porto Alegre, 135, Annes Dias St., Porto Alegre, Rio Grande Do Sul, RS, 90040-001, Brazil. francine.dermato@gmail.com.ORCID http://orcid.org/0000-0003-2274-7546
Patrícia Lima BaptistaDepartment of Dermatology, Santa Casa de Misericórdia de Porto Alegre, 135, Annes Dias St., Porto Alegre, Rio Grande Do Sul, RS, 90040-001, Brazil.
Rodrigo Pereira DuquiaDepartment of Dermatology, Santa Casa de Misericórdia de Porto Alegre, 135, Annes Dias St., Porto Alegre, Rio Grande Do Sul, RS, 90040-001, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn March 2020, social isolation measures were imposed in Brazil to contain the spread of the novel coronavirus (SARS-CoV-2), requiring health services to implement contingency plans. The main objective of the study was to verify the status of the disease, self-reported by patients who discontinued phototherapy, during a period of social isolation.

methodsAll patients receiving phototherapy at the Santa Casa de Porto Alegre, Brazil, prior to the implementation of social distancing measures were eligible for inclusion in the study. 86 patients answered a questionnaire during a medical evaluation.

results95% of patients who stopped phototherapy reported a worsening of disease status. Only 19% of patients continued to attend phototherapy sessions during the social isolation period.

conclusionThe COVID-19 pandemic led most patients to stop phototherapy, resulting in the perception of increased disease severity in an outpatient sample in southern Brazil.

Indexed as

COVID-19PhototherapyTreatment RefusalBrazilCross-Sectional StudiesFemaleHumansLymphoma, T-Cell, CutaneousMalePsoriasisSeverity of Illness IndexSocial IsolationSurveys and QuestionnairesVitiligoCOVID-19Cutaneous T-cell lymphomaPhototherapyPsoriasisVitiligo

Identifiers

PMID34449079
PMCPMC8393778

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.